🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Healthstream executive sells $26,185 in company stock

Published 02/05/2024, 00:26
HSTM
-

HealthStream Inc (NASDAQ:HSTM) Senior Vice President Scott Fenstermacher sold shares in the company, according to a recent filing with the Securities and Exchange Commission. The transaction, dated May 1, 2024, involved the sale of 1,000 shares of HealthStream common stock at a weighted average price of $26.1858 per share, totaling approximately $26,185.

The sale was executed in multiple trades with prices ranging from $26.17 to $26.20. Following the transaction, Fenstermacher's direct holdings in the company decreased to 13,008 shares of common stock.

HealthStream, based in Nashville, Tennessee, specializes in computer programming, data processing, and other related services within the technology sector. The company's shares are publicly traded on the NASDAQ exchange under the ticker symbol HSTM.

Investors and followers of HealthStream will note that the reported transaction provides a snapshot of insider activity, which can be an indicator of the executive's confidence in the company's current valuation and future prospects. However, it's important to consider that such sales could be motivated by a variety of personal financial needs or portfolio strategies and not necessarily a reflection on the company's performance.

The SEC filing provides detailed information regarding the transaction and affirms the executive's commitment to transparency by offering to provide full details of the trades upon request.

InvestingPro Insights

Amidst the recent insider trading activity at HealthStream Inc (NASDAQ:HSTM), investors might benefit from considering some key financial metrics and insights that could shed light on the company's current position and future potential. According to InvestingPro data, HealthStream boasts a market capitalization of approximately $792.47 million, reflecting its standing within the technology sector and investor valuation.

An analysis of the company's earnings reveals a Price-to-Earnings (P/E) ratio of 44.71, which when adjusted for the last twelve months as of Q1 2024, stands slightly higher at 44.81. This metric suggests investors are willing to pay a premium for HealthStream's earnings, which could be justified by the company's growth prospects or market position. Additionally, the company's Price/Earnings to Growth (PEG) ratio for the same period is 0.88, indicating that the stock may be reasonably priced relative to its earnings growth expectations.

InvestingPro Tips highlight that HealthStream has a perfect Piotroski Score of 9, suggesting strong financial health, and management has been actively buying back shares, which could signal confidence in the company's value. Furthermore, HealthStream holds more cash than debt on its balance sheet, which is a positive sign of financial stability. For investors looking for more in-depth analysis, there are over 10 additional InvestingPro Tips available for HealthStream at Investing.com. Utilize the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription, and gain access to valuable insights that could inform your investment decisions.

As HealthStream navigates the competitive landscape of the technology sector, these financial metrics and InvestingPro Tips provide a more comprehensive view of the company's performance and potential, beyond the insider transactions that often capture headlines.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.